Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 112 Pages
Report ld: 2654740
Request Sample
Customized Report
Heparin Sodium Market Size(US$)

CAGR 2024-2030
6.2%
Market Size,2030
USD 4,200.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
The global Heparin Sodium market is projected to grow from US$ 2934.6 million in 2024 to US$ 4200.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Changshan Biochemical and Dongcheng Biochemicals. Global top five manufacturers hold a share about 57%. Europe is the largest market, with a share about 55%, followed by China and North America, total with a share about 35 percent. In terms of application, the largest application is Low Molecular Weight Heparin Preparations, followed by Standard Heparin Preparation.
Report Covers:
This report presents an overview of global market for Heparin Sodium, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Heparin Sodium, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Heparin Sodium, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Heparin Sodium sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Heparin Sodium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Heparin Sodium sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Heparin Sodium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heparin Sodium sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Heparin Sodium Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Sodium Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Type A
1.2.3 Type B
1.3 Market by Application
1.3.1 Global Heparin Sodium Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Standard Heparin Preparation
1.3.3 Low Molecular Weight Heparin Preparations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Heparin Sodium Sales Estimates and Forecasts 2019-2030
2.2 Global Heparin Sodium Revenue by Region
2.2.1 Global Heparin Sodium Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Heparin Sodium Revenue by Region (2019-2024)
2.2.3 Global Heparin Sodium Revenue by Region (2025-2030)
2.2.4 Global Heparin Sodium Revenue Market Share by Region (2019-2030)
2.3 Global Heparin Sodium Sales Estimates and Forecasts 2019-2030
2.4 Global Heparin Sodium Sales by Region
2.4.1 Global Heparin Sodium Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Heparin Sodium Sales by Region (2019-2024)
2.4.3 Global Heparin Sodium Sales by Region (2025-2030)
2.4.4 Global Heparin Sodium Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Heparin Sodium Sales by Manufacturers
3.1.1 Global Heparin Sodium Sales by Manufacturers (2019-2024)
3.1.2 Global Heparin Sodium Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Heparin Sodium in 2023
3.2 Global Heparin Sodium Revenue by Manufacturers
3.2.1 Global Heparin Sodium Revenue by Manufacturers (2019-2024)
3.2.2 Global Heparin Sodium Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Heparin Sodium Revenue in 2023
3.3 Global Key Players of Heparin Sodium, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Heparin Sodium Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Heparin Sodium, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Heparin Sodium, Product Offered and Application
3.8 Global Key Manufacturers of Heparin Sodium, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Heparin Sodium Sales by Type
4.1.1 Global Heparin Sodium Historical Sales by Type (2019-2024)
4.1.2 Global Heparin Sodium Forecasted Sales by Type (2025-2030)
4.1.3 Global Heparin Sodium Sales Market Share by Type (2019-2030)
4.2 Global Heparin Sodium Revenue by Type
4.2.1 Global Heparin Sodium Historical Revenue by Type (2019-2024)
4.2.2 Global Heparin Sodium Forecasted Revenue by Type (2025-2030)
4.2.3 Global Heparin Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Heparin Sodium Price by Type
4.3.1 Global Heparin Sodium Price by Type (2019-2024)
4.3.2 Global Heparin Sodium Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Heparin Sodium Sales by Application
5.1.1 Global Heparin Sodium Historical Sales by Application (2019-2024)
5.1.2 Global Heparin Sodium Forecasted Sales by Application (2025-2030)
5.1.3 Global Heparin Sodium Sales Market Share by Application (2019-2030)
5.2 Global Heparin Sodium Revenue by Application
5.2.1 Global Heparin Sodium Historical Revenue by Application (2019-2024)
5.2.2 Global Heparin Sodium Forecasted Revenue by Application (2025-2030)
5.2.3 Global Heparin Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Heparin Sodium Price by Application
5.3.1 Global Heparin Sodium Price by Application (2019-2024)
5.3.2 Global Heparin Sodium Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Heparin Sodium Market Size by Type
6.1.1 US & Canada Heparin Sodium Sales by Type (2019-2030)
6.1.2 US & Canada Heparin Sodium Revenue by Type (2019-2030)
6.2 US & Canada Heparin Sodium Market Size by Application
6.2.1 US & Canada Heparin Sodium Sales by Application (2019-2030)
6.2.2 US & Canada Heparin Sodium Revenue by Application (2019-2030)
6.3 US & Canada Heparin Sodium Market Size by Country
6.3.1 US & Canada Heparin Sodium Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Heparin Sodium Sales by Country (2019-2030)
6.3.3 US & Canada Heparin Sodium Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Heparin Sodium Market Size by Type
7.1.1 Europe Heparin Sodium Sales by Type (2019-2030)
7.1.2 Europe Heparin Sodium Revenue by Type (2019-2030)
7.2 Europe Heparin Sodium Market Size by Application
7.2.1 Europe Heparin Sodium Sales by Application (2019-2030)
7.2.2 Europe Heparin Sodium Revenue by Application (2019-2030)
7.3 Europe Heparin Sodium Market Size by Country
7.3.1 Europe Heparin Sodium Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Heparin Sodium Sales by Country (2019-2030)
7.3.3 Europe Heparin Sodium Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Heparin Sodium Market Size
8.1.1 China Heparin Sodium Sales (2019-2030)
8.1.2 China Heparin Sodium Revenue (2019-2030)
8.2 China Heparin Sodium Market Size by Application
8.2.1 China Heparin Sodium Sales by Application (2019-2030)
8.2.2 China Heparin Sodium Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Heparin Sodium Market Size by Type
9.1.1 Asia Heparin Sodium Sales by Type (2019-2030)
9.1.2 Asia Heparin Sodium Revenue by Type (2019-2030)
9.2 Asia Heparin Sodium Market Size by Application
9.2.1 Asia Heparin Sodium Sales by Application (2019-2030)
9.2.2 Asia Heparin Sodium Revenue by Application (2019-2030)
9.3 Asia Heparin Sodium Sales by Region
9.3.1 Asia Heparin Sodium Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Heparin Sodium Revenue by Region (2019-2030)
9.3.3 Asia Heparin Sodium Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Heparin Sodium Market Size by Type
10.1.1 Middle East, Africa and Latin America Heparin Sodium Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Heparin Sodium Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Heparin Sodium Market Size by Application
10.2.1 Middle East, Africa and Latin America Heparin Sodium Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Heparin Sodium Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Heparin Sodium Sales by Country
10.3.1 Middle East, Africa and Latin America Heparin Sodium Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Heparin Sodium Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Heparin Sodium Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Shenzhen Hepalink
11.1.1 Shenzhen Hepalink Company Information
11.1.2 Shenzhen Hepalink Overview
11.1.3 Shenzhen Hepalink Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Shenzhen Hepalink Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shenzhen Hepalink Recent Developments
11.2 Nanjing King-friend
11.2.1 Nanjing King-friend Company Information
11.2.2 Nanjing King-friend Overview
11.2.3 Nanjing King-friend Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Nanjing King-friend Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nanjing King-friend Recent Developments
11.3 Bioiberica
11.3.1 Bioiberica Company Information
11.3.2 Bioiberica Overview
11.3.3 Bioiberica Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bioiberica Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bioiberica Recent Developments
11.4 Dongcheng Biochemicals
11.4.1 Dongcheng Biochemicals Company Information
11.4.2 Dongcheng Biochemicals Overview
11.4.3 Dongcheng Biochemicals Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Dongcheng Biochemicals Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dongcheng Biochemicals Recent Developments
11.5 Changzhou Qianhong Bio-pharma
11.5.1 Changzhou Qianhong Bio-pharma Company Information
11.5.2 Changzhou Qianhong Bio-pharma Overview
11.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Changzhou Qianhong Bio-pharma Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Pfizer Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Changshan Biochemical
11.7.1 Changshan Biochemical Company Information
11.7.2 Changshan Biochemical Overview
11.7.3 Changshan Biochemical Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Changshan Biochemical Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changshan Biochemical Recent Developments
11.8 Aspen Oss
11.8.1 Aspen Oss Company Information
11.8.2 Aspen Oss Overview
11.8.3 Aspen Oss Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Aspen Oss Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aspen Oss Recent Developments
11.9 Opocrin
11.9.1 Opocrin Company Information
11.9.2 Opocrin Overview
11.9.3 Opocrin Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Opocrin Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Opocrin Recent Developments
11.10 Qingdao Jiulong Biopharmaceutical
11.10.1 Qingdao Jiulong Biopharmaceutical Company Information
11.10.2 Qingdao Jiulong Biopharmaceutical Overview
11.10.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Qingdao Jiulong Biopharmaceutical Recent Developments
11.11 Yino Pharma Limited
11.11.1 Yino Pharma Limited Company Information
11.11.2 Yino Pharma Limited Overview
11.11.3 Yino Pharma Limited Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Yino Pharma Limited Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Yino Pharma Limited Recent Developments
11.12 Dongying Tiandong Pharmaceutical
11.12.1 Dongying Tiandong Pharmaceutical Company Information
11.12.2 Dongying Tiandong Pharmaceutical Overview
11.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dongying Tiandong Pharmaceutical Recent Developments
11.13 Xinbai Pharmaceuticals
11.13.1 Xinbai Pharmaceuticals Company Information
11.13.2 Xinbai Pharmaceuticals Overview
11.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Xinbai Pharmaceuticals Recent Developments
11.14 Laboratorios Farmaceuticos ROVI
11.14.1 Laboratorios Farmaceuticos ROVI Company Information
11.14.2 Laboratorios Farmaceuticos ROVI Overview
11.14.3 Laboratorios Farmaceuticos ROVI Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Laboratorios Farmaceuticos ROVI Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Laboratorios Farmaceuticos ROVI Recent Developments
11.15 Sichuan Deebio
11.15.1 Sichuan Deebio Company Information
11.15.2 Sichuan Deebio Overview
11.15.3 Sichuan Deebio Heparin Sodium Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Sichuan Deebio Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sichuan Deebio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Heparin Sodium Industry Chain Analysis
12.2 Heparin Sodium Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Heparin Sodium Production Mode & Process
12.4 Heparin Sodium Sales and Marketing
12.4.1 Heparin Sodium Sales Channels
12.4.2 Heparin Sodium Distributors
12.5 Heparin Sodium Customers
13 Market Dynamics
13.1 Heparin Sodium Industry Trends
13.2 Heparin Sodium Market Drivers
13.3 Heparin Sodium Market Challenges
13.4 Heparin Sodium Market Restraints
14 Key Findings in The Global Heparin Sodium Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Heparin Sodium market size was US$ 3185 million in 2025 and is forecast to reach a readjusted size of US$ 4812 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 94
USD 4250.00
(Single User License)
The global Heparin Sodium market was valued at US$ 3185 million in 2025 and is anticipated to reach US$ 4812 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 125
USD 2900.00
(Single User License)
The global market for Heparin Sodium was estimated to be worth US$ 3185 million in 2025 and is projected to reach US$ 4812 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 3950.00
(Single User License)
The global Heparin Sodium market is projected to grow from US$ 3018 million in 2024 to US$ 4560 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 159
USD 4900.00
(Single User License)
In 2024, the global market size of Heparin Sodium was estimated to be worth US$ 3018 million and is forecast to reach approximately US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 150
USD 5900.00
(Single User License)
The global Heparin Sodium market size was US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 93
USD 4250.00
(Single User License)
The global market for Heparin Sodium was estimated to be worth US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 130
USD 3950.00
(Single User License)
The global market for Heparin Sodium was valued at US$ 3018 million in the year 2024 and is projected to reach a revised size of US$ 4560 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published Date: 2025-01-16
Pages: 91
USD 2900.00
(Single User License)
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published Date: 2024-04-16
Pages: 172
USD 5900.00
(Single User License)
The global Heparin Sodium market size was US$ 3185 million in 2025 and is forecast to reach a readjusted size of US$ 4812 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 94
The global Heparin Sodium market was valued at US$ 3185 million in 2025 and is anticipated to reach US$ 4812 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 125
The global market for Heparin Sodium was estimated to be worth US$ 3185 million in 2025 and is projected to reach US$ 4812 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
The global Heparin Sodium market is projected to grow from US$ 3018 million in 2024 to US$ 4560 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 159
In 2024, the global market size of Heparin Sodium was estimated to be worth US$ 3018 million and is forecast to reach approximately US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 150
The global Heparin Sodium market size was US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 93
The global market for Heparin Sodium was estimated to be worth US$ 3018 million in 2024 and is forecast to a readjusted size of US$ 4560 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 130
The global market for Heparin Sodium was valued at US$ 3018 million in the year 2024 and is projected to reach a revised size of US$ 4560 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-01-16
Pages: 91
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published: 2024-04-17
Pages: 177
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Published: 2024-04-16
Pages: 172
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now